Figure 2
From: Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer
Probability of OS for patients with vs. without local treatment on Kaplan-Meier Method in HER2-enriched Subgroup.
Figure 2 | SpringerPlus